WHO ICTRP trial
FPF3400 long-term study in patients who require selenium supplementation - A…
JPRN-jRCT2080222756 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080222756 |
|---|---|
| Public title | FPF3400 long-term study in patients who require selenium supplementation - A multicenter open study - |
| Scientific title | FPF3400 long-term study in patients who require selenium supplementation - A multicenter open study - |
| Primary sponsor | Fujimoto Pharmaceutical Corporation |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Hyposelenemia |
| Interventions | investigational material(s) Generic name etc : FPF3400 INN of investigational material : - Therapeutic category code : 32- Nutrients, tonics and alteratives Dosage and Administration for Investigational material : intravenous injection… |
| Registration date | Feb 13, 2015 |
| Target size | 40 |
| Secondary IDs | JapicCTI-152808 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: